17 Jul 2020 --- Probiotics player Probi has released its financial results for Q2, highlighting net sales amounted to SEK 180 million (US$19.9 million) during this quarter on par with the previous year. Notably, the company states the overall effect of the COVID-19 pandemic on its business operations was “neutral,” which coincided with heightened demand for probiotics and immune health boosting products. With this financial forecast, Probi says it is set to double its annual sales within five to seven years.
